Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.
WARSAW — Bowen Health has announced that president and CEO Dr. Rob Ryan has been appointed to the American Hospital ...
DHR sees Biotechnology core revenues rise 6.5% in Q3 2025, fueled by bioprocessing demand, with approximately 5% growth expected in Q4.
A St. Louis biotech company has secured new funding from a major lab services business and a health system venture capital ...
Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.
Labcorp Holdings recently reported better-than-expected Q3 2025 adjusted EPS of $4.18 but cut its contract research unit’s annual and full-year revenue growth forecasts due to a prolonged funding ...
Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.
Hosted on MSN
Labcorp announces board member retirement
Labcorp Holdings ( (LH)) has provided an update. On December 10, 2025, Labcorp Holdings announced the retirement of Dr. D. Gary Gilliland from its Board of Directors, effective December 31, 2025. Dr.
Labcorp Holdings (LH) has quietly outperformed many healthcare peers this year, and the stock’s recent move has investors asking whether steady earnings growth and diagnostics demand can keep driving ...
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...
Labcorp is a science and healthcare company that provides laboratory testing services worldwide. It also functions as a lab facility that conducts research, clinical studies, diagnostic testing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback